| Business Type | Exporter, Supplier, Retailer |
| Packaging | Box |
| Color | White |
| Composition | Enasidenib 50mg |
| Click to view more | |
Product Details
COMPOSITION:
Each tablet contains: Enasidenib……… 50mg
INDICATION:
LuciEna is an isocitrate dehydrogenase-2 inhibitor indicated for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) with an isocitrate dehydrogenase-2 (IDH2) mutation.
DOSAGE AND USE:
The recommended dosage of LuciEna is 100 mg taken orally once daily with or without food until disease progression or unacceptable toxicity.
Tablet should be swallowed whole & not chewed or crushed.COMPOSITION:
Each tablet contains: Enasidenib……… 50mg
INDICATION:
LuciEna is an isocitrate dehydrogenase-2 inhibitor indicated for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) with an isocitrate dehydrogenase-2 (IDH2) mutation.
DOSAGE AND USE:
The recommended dosage of LuciEna is 100 mg taken orally once daily with or without food until disease progression or unacceptable toxicity.
Tablet should be swallowed whole & not chewed or crushed.
* Currently we are not Accepting Orders for this Product.
